Innovative marketing strategies after patent expiry: The case of GSK's antibiotic Clamoxyl in France

Journal of Generic Medicines

Volumn 1, Issue 4, 2004, Pages 353-361

  Chandon, Pierre ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN; GENERIC DRUG; MACROLIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; COMPETITION; COST BENEFIT ANALYSIS; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; HUMAN; PATENT; POLITICAL SYSTEM;

EID: 33846881807     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940041     Document Type: Article

References (2)

1. This paper was first published in International Journal of Medical Marketing, Vol. 4, No. 1, pp. 65-73, by Henry Stewart Publications.
2. Marketing its own generics was not considered at that time for a variety of reasons.